Search Results
186 items found for "high grade serous ovarian cancer"
- GRK2 in cardiovascular disease and its potential as a therapeutic target
particularly in the field of heart failure (HF) research, case numbers and overall mortality remain high and deleterious signaling pathways in the heart, indicating that these domains can be targeted with a high
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
exclusivity on data related to GPCR implicated in immunoresistance, to develop first-in class innovative cancer
- Newly launched antibody libraries put hard-to-drug targets within reach
November 2021 "Target class-specific libraries mean you need to screen less to identify high-quality Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics
- Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...
The suppressive rather than activating effects of pGRP were confined to blood flow at a high shear rate in collagen- and GPVI-dependent thrombus formation, which is modulated by GPR56 and exclusively at high
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
have been developed, with a focus on small molecules and monoclonal antibodies for the treatment of cancer
- 📰 GPCR Weekly News, June 5 to 11, 2023
Autocrine Proteinase-Activated Receptor (PAR) signaling in PC3 prostate cancer cells. GPCRs in Immunology and Oncology The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
receptor (A2AAR) have been considered promising agents to treat Parkinson's disease, inflammation, cancer
- Profiling Immune Cell and Platelet Transcriptomes
26 receptors identified in the previous study not detected in the current analysis, suggesting that variations also opens doors for exploring the roles of these receptors in various pathological states, including cancer
- 📰 GPCR Weekly News, February 6 to 12, 2023
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic cancer
- 📰 GPCR Weekly News, January 8 to 14, 2024
Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in MCF7 breast cancer activation of the adhesion receptor CD97 GPCR Activation and Signaling Biased Signaling in Mutated Variants guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer
- Ginsenoside Rg5 allosterically interacts with P2RY12 and ameliorates deep venous thrombosis by...
venous thrombosis (DVT) highly occurs in patients with severe COVID-19 and probably accounted for their high
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development and cancer
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCRs in Oncology and Immunology GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer.
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
For example, chemotherapy, a powerful standard approach to kill fast-growing cancer cells, has the drawback
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
Twenty transition structures generated from overlapping particle subsets along this pathway provide a high-resolution With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
scientists uncover “plant-like” behavior in important human cell regulator, opening up a new drug target for cancer spinal cord injury GPCRs in Oncology and Immunology Biochemical pharmacology of adenylyl cyclases in cancer
- Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
Interestingly, there were also significant differences in receptor degradation, with S339fs5 having a very high promotes enhanced signaling, reduced phosphorylation, β-arrestin binding and endocytosis, and a very high
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins rate (45.00%), body malformation, abnormal wing expansion, failed cuticle melanization (63.33%), and high
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Staff Scientist, Computational Chemistry GPCR Activation and Signaling GPCR signalling: Yet another variant mouse neutrophils Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking The Effect of Cancer-Associated Mutations
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
Steyaert bridged fundamental high-impact research in biomedical sciences with the mechanistic understanding
- Emerging approaches for decoding neuropeptide transmission
produce robust effects on behavior across species, and recent research has benefited from advances in high-resolution
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for cancer therapy Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration
- Lysosomal GPCR-like protein LYCHOS signals cholesterol sufficiency to mTORC1
At high cholesterol concentrations, LYCHOS bound to the GATOR1 complex, a guanosine triphosphatase (GTPase
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Nominated for Prestigious Prix Galien USA ‘Best Startup’ Award: Pioneering GPCR-Driven Immunotherapies in Cancer future directions Going rogue: mechanisms, regulation, and roles of mutationally activated Gα in human cancer class C GPCR dimer mGlu5 Altered O-glycosylation of β1-adrenergic receptor N-terminal single-nucleotide variants
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
New high-resolution structures of CB1 receptor in different functional states have significantly improved
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
To exert their functions requiring high sensibility and specificity, T cells need to integrate different
- AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors
structure models in the functional study and structure-based drug design of GPCRs, which required reliable high-resolution
- Canonical chemokine receptors as scavenging “decoys”
in the chemokine system can also contribute to various diseases, such as inflammatory conditions and cancer